HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CEO Lafley Defends P&G’s Long-Term Strategy, Sense Of Balance

This article was originally published in The Rose Sheet

Executive Summary

P&G’s chief exec tells analysts that with a portfolio that creates value for consumers across the high-, mid- and lower-price product categories, the firm is well-positioned for long-term growth.

You may also be interested in...



P&G Beauty Biz Stalled, But Room For Growth Exists – CEO Lafley

During an Aug. 1 earnings call, P&G CEO A.G. Lafley outlined his plan to bring the firm back to solid fiscal returns. The firm will focus on productivity and innovation and looks to grow its beauty segment by concentrating on smaller brands in skin care and hair care and by maintaining the strong momentum of its prestige business.

P&G Promises Greater Innovation In Personal Care After Lackluster Q3

Recent struggles cause Procter & Gamble to knock down its full-year earnings-per-share guidance. Questioned by analysts, CEO Bob McDonald accepts blame and promises that P&G “will deliver.” The firm’s U.S. grooming and oral-care businesses have taken hits due to “unprecedented” promotional spending by competitors, according to company leadership.

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel